| Year |
Citation |
Score |
| 2023 |
Pellegrini H, Sharpe EH, Liu G, Nishiuchi E, Doerr N, Kipp KR, Chin T, Schimmel MF, Weimbs T. Cleavage fragments of the C-terminal tail of polycystin-1 are regulated by oxidative stress and induce mitochondrial dysfunction. The Journal of Biological Chemistry. 105158. PMID 37579949 DOI: 10.1016/j.jbc.2023.105158 |
0.56 |
|
| 2022 |
Akbari M, West JD, Doerr N, Kipp KR, Marhamati N, Vuong S, Wang Y, Rinschen MM, Talbot JJ, Wessely O, Weimbs T. Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression. Proceedings of the National Academy of Sciences of the United States of America. 119: e2121267119. PMID 35867829 DOI: 10.1073/pnas.2121267119 |
0.757 |
|
| 2018 |
Olsan EE, West JD, Torres JA, Doerr N, Weimbs T. Identification of Targets of Interleukin-13 and Signal Transducer and Activator of Transcription-6 (STAT6) Signaling in Polycystic Kidney Disease. American Journal of Physiology. Renal Physiology. PMID 29513071 DOI: 10.1152/Ajprenal.00346.2017 |
0.691 |
|
| 2016 |
Doerr N, Wang Y, Kipp KR, Liu G, Benza JJ, Pletnev V, Pavlov TS, Staruschenko A, Mohieldin AM, Takahashi M, Nauli SM, Weimbs T. Regulation of Polycystin-1 Function by Calmodulin Binding. Plos One. 11: e0161525. PMID 27560828 DOI: 10.1371/Journal.Pone.0161525 |
0.746 |
|
| 2015 |
Rothé B, Leal-Esteban L, Bernet F, Urfer S, Doerr N, Weimbs T, Iwaszkiewicz J, Constam DB. Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA. Molecular and Cellular Biology. 35: 3339-53. PMID 26217012 DOI: 10.1128/Mcb.00341-15 |
0.697 |
|
| 2014 |
Talbot JJ, Song X, Wang X, Rinschen MM, Doerr N, LaRiviere WB, Schermer B, Pei YP, Torres VE, Weimbs T. The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation. Journal of the American Society of Nephrology : Jasn. 25: 1737-48. PMID 24578126 DOI: 10.1681/Asn.2013091026 |
0.799 |
|
| 2011 |
Talbot JJ, Shillingford JM, Vasanth S, Doerr N, Mukherjee S, Kinter MT, Watnick T, Weimbs T. Polycystin-1 regulates STAT activity by a dual mechanism. Proceedings of the National Academy of Sciences of the United States of America. 108: 7985-90. PMID 21518865 DOI: 10.1073/Pnas.1103816108 |
0.735 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2008 |
La DS, Belzile J, Bready JV, Coxon A, DeMelfi T, Doerr N, Estrada J, Flynn JC, Flynn SR, Graceffa RF, Harriman SP, Larrow JF, Long AM, Martin MW, Morrison MJ, et al. Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis. Journal of Medicinal Chemistry. 51: 1695-705. PMID 18311900 DOI: 10.1021/jm701129j |
0.149 |
|
| 2007 |
Potashman MH, Bready J, Coxon A, DeMelfi TM, DiPietro L, Doerr N, Elbaum D, Estrada J, Gallant P, Germain J, Gu Y, Harmange JC, Kaufman SA, Kendall R, Kim JL, et al. Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors. Journal of Medicinal Chemistry. 50: 4351-73. PMID 17696416 DOI: 10.1021/jm070034i |
0.127 |
|
| 2004 |
Redlich K, Görtz B, Hayer S, Zwerina J, Doerr N, Kostenuik P, Kollias G, Steiner G, Smolen J, Schett G. Arthritis Research & Therapy. 6: 63. DOI: 10.1186/ar1105 |
0.12 |
|
| 2003 |
Redlich K, Goertz B, Doerr N, Kollias G, Steiner G, Smolen J, Schett G. Arthritis Research & Therapy. 5: 126. DOI: 10.1186/AR927 |
0.12 |
|
| 2008 |
Weiss MM, Harmange JC, Polverino AJ, Bauer D, Berry L, Berry V, Borg G, Bready J, Chen D, Choquette D, Coxon A, DeMelfi T, Doerr N, Estrada J, Flynn J, et al. Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors. Journal of Medicinal Chemistry. 51: 1668-80. PMID 18324759 DOI: 10.1021/jm701098w |
0.108 |
|
| 2008 |
Harmange JC, Weiss MM, Germain J, Polverino AJ, Borg G, Bready J, Chen D, Choquette D, Coxon A, DeMelfi T, DiPietro L, Doerr N, Estrada J, Flynn J, Graceffa RF, et al. Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation. Journal of Medicinal Chemistry. 51: 1649-67. PMID 18324761 DOI: 10.1021/jm701097z |
0.107 |
|
| 2004 |
Redlich K, Görtz B, Hayer S, Zwerina J, Doerr N, Kostenuik P, Bergmeister H, Kollias G, Steiner G, Smolen JS, Schett G. Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. The American Journal of Pathology. 164: 543-55. PMID 14742260 DOI: 10.1016/S0002-9440(10)63144-6 |
0.027 |
|
| Hide low-probability matches. |